Chemotherapy & ImmunotherapyHead and Neck Cancer Study Project in the Geriatric Population

Sponsor:

Brown University

Code:

NCT06998069

Conditions

Head and Neck Neoplasms

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Arm I Carboplatin, Paclitaxel, Pembrolizumab

Arm II Carboplatin, Paclitaxel, Cetuximab

Arm III Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Brown University on 2026-08-20.